What is NUWAY Alliance?
Established in 1966, NUWAY Alliance operates as a specialized non-profit entity dedicated to the recovery of individuals navigating substance use and mental health challenges. The organization distinguishes itself as a pioneer in the field, notably as the first institution to implement the Co-Occurring Disorders Program (CDP) developed by Dartmouth Medical School and the Hazelden Foundation. With a legacy spanning over five decades and a track record of serving more than 40,000 individuals, NUWAY maintains a market position defined by clinical rigor and a commitment to integrated care models that treat substance use and mental health disorders with equal clinical priority.
How much funding has NUWAY Alliance raised?
NUWAY Alliance has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in NUWAY Alliance
PPP
Public-Private Partnership
What's next for NUWAY Alliance?
With the recent influx of capital, NUWAY Alliance is positioned to scale its service delivery models and enhance its infrastructure for long-term sustainability. The organization's strategic roadmap likely involves expanding the reach of its Co-Occurring Disorders Program to meet the rising demand for integrated behavioral health interventions. By maintaining its focus on high-impact, evidence-based recovery, NUWAY is well-equipped to navigate the evolving landscape of non-profit healthcare, ensuring that its mission-driven approach remains resilient against shifting economic and regulatory pressures in the addiction recovery sector.
See full NUWAY Alliance company page
